Omalizumab Subcutaneous and Panatuss DXP
Determining the interaction of Omalizumab Subcutaneous and Panatuss DXP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: dexbrompheniramine / dextromethorphan / phenylephrine
Brand name: Alahist CF, G-P-Tuss DXP, Panatuss DXP, Supress A Pediatric, Alahist DM, Bionatuss, Supress A, Tussall, Tussall-ER, Dexall, Y-Cof DM, Panatuss Pediatric DXP
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Panatuss PED
- Omalizumab Subcutaneous-Panatuss PED Drops
- Omalizumab Subcutaneous-Pancof HC
- Omalizumab Subcutaneous-Pancof XP
- Omalizumab Subcutaneous-Pancreatin
- Omalizumab Subcutaneous-Pancreatin 4X
- Panatuss DXP-Ombitasvir, Paritaprevir, and Ritonavir
- Panatuss DXP-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Panatuss DXP-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Panatuss DXP-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Panatuss DXP-Omeclamox-Pak
- Panatuss DXP-Omega-3 Fatty Acid Capsules